MedPath

Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

Phase 4
Completed
Conditions
Infertility
Interventions
Registration Number
NCT01419353
Lead Sponsor
Meir Medical Center
Brief Summary

The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.

Detailed Description

A randomised controlled trial in which study group will be given estrogen derivative before ovarian stimulation in GnRH antagonist protocol and compared to the classical GnRH agonist protocol.Estrogen will be given P.O , "PROGYNOVA' , in a dose of 2 mg /d, starting day 2 of menses and until first Monday to follow. Main outcome measure will be ability to control the ovum pickup day, calculated as a rate of ideal pickups divided by the entire pickup number. All women enrolled will be under 38 years of age, with a clear indication for IVF other than ovulatory dysfunction. women with past 4 treatment failures will be excluded as well as cases in which sperm achieved in surgical methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
63
Inclusion Criteria
  • IVF treatment in the following indications: Male, Mechanical, Unexplained
  • Age<38 years
  • Treatment Cycle number 1-4
Exclusion Criteria
  • Ovulatory disorder as an indication for IVF
  • Repeated failure in previous IVF treatments (> than 4 cycles)
  • Sperm used for treatment was retrieved by surgical procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Follicular Estrogen, Antagonist, IVFestradiol valerateFollicular Estrogen in Antagonist IVF protocol
long IVF protocolestradiol valeratelong IVF protocol
Primary Outcome Measures
NameTimeMethod
ovum pickup rate that took place between Sunday to Thursday without a compromisea year

number of Pickups that took place between Sunday to Thursday (without a compromise in treatment) \\ by the entire pickup number

Secondary Outcome Measures
NameTimeMethod
pregnancy ratea year

comparison of pregnancy rate between the 2 groups. calculated per cycle

Trial Locations

Locations (1)

Meir Medical Center

🇮🇱

Kfar Saba, Israel

© Copyright 2025. All Rights Reserved by MedPath